Neuropace, Inc.
NPCEMedical Devices
$12.30−5.46%As of Oct 30vs prior close
- Market cap
- $422.2M
- P/E (TTM)
- –
- From 52W high
- −36.24%
- EPS (LTM)
- -$0.57
- Revenue (LTM)
- $102.9M
- Net margin
- -18.58%
- Dividend yield
- 0.00%
Nomior Score
45
Steady ProfileBottom 39% of the scored universe
Growth58
Quality39
Value42
Momentum63
Resilience38
Growth
+19.44%revenue a year over 5 fiscal years
YE20 $41.1MLTM $102.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 23% of revenue, narrower by 19 pts on a year.
Who owns it
2funds